HIPK2 role in the tumor–host interaction: Impact on fibroblasts transdifferentiation CAF‐like
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIPK2 role in the tumor–host interaction: Impact on fibroblasts transdifferentiation CAF‐like
Authors
Keywords
-
Journal
IUBMB LIFE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-15
DOI
10.1002/iub.2144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
- (2017) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- From inflammation to cancer
- (2016) A. Korniluk et al. IRISH JOURNAL OF MEDICAL SCIENCE
- ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose
- (2016) A Garufi et al. Cell Death & Disease
- Hyperglycemia triggers HIPK2 protein degradation
- (2016) Silvia Baldari et al. Oncotarget
- Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
- (2016) Alessandro Arcucci et al. Biomed Research International
- Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
- (2016) Serena Stanga et al. Aging-US
- HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation
- (2016) Lavinia Nardinocchi et al. Aging-US
- Caveolin-1 is a Modulator of Fibroblast Activation and a Potential Biomarker for Gastric Cancer
- (2015) Xiao-Jun Shen et al. International Journal of Biological Sciences
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications
- (2015) S Baldari et al. Cell Death & Disease
- Oxidative stress and autophagy: the clash between damage and metabolic needs
- (2014) G Filomeni et al. CELL DEATH AND DIFFERENTIATION
- High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
- (2014) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review)
- (2014) DALI CHEN et al. Oncology Letters
- Hyperglycemia, a Neglected Factor during Cancer Progression
- (2014) Wanxing Duan et al. Biomed Research International
- Autophagy, Warburg, and Warburg Reverse Effects in Human Cancer
- (2014) Claudio D. Gonzalez et al. Biomed Research International
- Hyperglycemia as a Risk Factor for Cancer Progression
- (2014) Tae Young Ryu et al. Diabetes & Metabolism Journal
- Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy
- (2013) A Garufi et al. Cell Death & Disease
- HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
- (2012) Cristina Nodale et al. CANCER BIOLOGY & THERAPY
- Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
- (2012) Gabriella D’Orazi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
- (2012) Alessia Garufi et al. PLoS One
- Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function
- (2011) Ofer Margalit et al. INTERNATIONAL JOURNAL OF CANCER
- HIPK2--A therapeutical target to be (re)activated for tumor suppression: Role in p53 activation and HIF-1α inhibition
- (2010) Lavinia Nardinocchi et al. CELL CYCLE
- Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis
- (2010) Rosa Puca et al. FREE RADICAL BIOLOGY AND MEDICINE
- Negative Regulation of 4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression
- (2009) G. Bon et al. CANCER RESEARCH
- Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests a novel mechanism to restrain tumor growth
- (2008) Lavinia Nardinocchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Reversible Dysfunction of Wild-Type p53 following Homeodomain-Interacting Protein Kinase-2 Knockdown
- (2008) R. Puca et al. CANCER RESEARCH
- Cancer cells suppress p53 in adjacent fibroblasts
- (2008) J Bar et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started